Ashley Flint


Ashley Flint provides strategic advice to life sciences clients on the impact of federal and state policy changes, with a focus on Inflation Reduction Act (IRA) implementation, drug pricing, Medicare Part D, and the 340B program.

Before joining Avalere, Ashley served as director of US policy & analytics at AbbVie, where she led a team responsible for analyzing proposed federal and state policies related to above-brand market access issues and developing policy positions and strategies that advanced business priorities. Previously, she was a senior director for policy & research at PhRMA where she served as the Part D policy lead. She was also an associate at HCM Strategists, providing policy support to hospital and patient advocacy groups.

Ashley holds an MPP in health policy from The George Washington University and a BA in political science and psychology from Emory University.

Authored Content

As federal and state policymakers debate the role of contract pharmacies (CPs) in 340B, Avalere analyzed how CP relationships inform the policy landscape.